Dr. Frey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 floor University Hospital Room B1g412
Ann Arbor, MI 48109Phone+1 734-936-5090
Education & Training
University of MichiganResidency, Nuclear Medicine, 1988 - 1989- University of MichiganResidency, Neurology, 1985 - 1988
Trinity Health Ann Arbor HospitalInternship, Internal Medicine, 1984 - 1985
University of Michigan Medical SchoolClass of 1984
Certifications & Licensure
MI State Medical License 1988 - 2025- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- PET Study of Non-Motor Symptoms of Parkinson Disease Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- 2 citationsSPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [Lu]Lu-DOTATATE.Johan Blakkisrud, Avery B Peterson, Scott J Wildermann, Griffen Kingkiner, Ka Kit Wong
Journal of Nuclear Medicine. 2024-05-01 - 3-[F]Fluoro--hydroxyphenethylguanidine (3-[F]pHPG) PET-A Novel Imaging Modality for Paraganglioma.Tobias Else, Ka Kit Wong, Kirk A Frey, Allen F Brooks, Benjamin L Viglianti
Journal of the Endocrine Society. 2024-04-06 - 1 citationsEnhancing precision: A predictive model forLu-DOTATATE treatment response in neuroendocrine tumors using quantitativeGa-DOTATATE PET and clinicopathological biomarkers.Azadeh Akhavanallaf, Sonal Joshi, Arathi Mohan, Francis P Worden, John C Krauss
Theranostics. 2024-01-01
Journal Articles
- Quantification of Brain Cholinergic Denervation in Dementia with Lewy Bodies Using PET Imaging with [18F]-FEOBVKirk A Frey, Roger L Albin, Nicolaas I Bohnen, Nature
Grant Support
- Cognitive Impairment And Decline In Parkinson DiseaseNational Institute Of Neurological Disorders And Stroke2008–2011
- AdministrationNational Institute Of Neurological Disorders And Stroke2008–2011
- PET Study Of Biochemistry And Metabolism Of The CNSNational Institute Of Neurological Disorders And Stroke2001–2011
- Striatal Dopamine /Motor Performance /Aging &ParkinsonsNational Institute Of Neurological Disorders And Stroke2001–2002
- Presynaptic Neurochemical MarkersNational Institute On Aging1996–2002
- PET Studies Of Parkinsons DiseaseNational Institute Of Neurological Disorders And Stroke1996–1999
- Emission Tomography Of Neuropharmacologic MarkersNational Institute Of Mental Health1992–1998
- Muscarinic Receptor Subtype RegulationNational Institute Of Mental Health1996–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
